Benzinga (Tue, 7-May 2:35 PM ET)
PEGY, MTC and IMTE among mid-day movers
Seeking Alpha News (Tue, 7-May 12:46 PM ET)
Helius Medical Technologies raises $6.4M via equity offering
Seeking Alpha News (Tue, 7-May 3:40 AM ET)
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
Globe Newswire (Mon, 6-May 10:15 PM ET)
XBP and MNTX among mid-day movers
Seeking Alpha News (Mon, 6-May 1:17 PM ET)
Globe Newswire (Mon, 6-May 9:00 AM ET)
GME, ONVO and POAI among pre-market losers
Seeking Alpha News (Mon, 6-May 8:26 AM ET)
CTMX, HSDT and SNSE are among premarket gainers
Seeking Alpha News (Fri, 3-May 8:29 AM ET)
Globe Newswire (Wed, 24-Apr 9:05 AM ET)
Globe Newswire (Wed, 3-Apr 7:05 AM ET)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Helius Medical Technologies - Class A trades on the NASDAQ stock market under the symbol HSDT.
As of May 7, 2024, HSDT stock price declined to $1.80 with 1,266,524 million shares trading.
HSDT has a beta of 1.99, meaning it tends to be more sensitive to market movements. HSDT has a correlation of 0.06 to the broad based SPY ETF.
HSDT has a market cap of $1.60 million. This is considered a Sub-Micro Cap stock.
Last quarter Helius Medical Technologies - Class A reported $134,000 in Revenue and -$1.47 earnings per share. This fell short of revenue expectation by $-116,000 and exceeded earnings estimates by $2.30.
In the last 3 years, HSDT stock traded as high as $863.00 and as low as $1.75.
The top ETF exchange traded funds that HSDT belongs to (by Net Assets): VXF.
HSDT has underperformed the market in the last year with a price return of -77.1% while the SPY ETF gained +27.0%. HSDT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -72.1% and -64.5%, respectively, while the SPY returned +5.0% and +3.5%, respectively.
HSDT support price is $2.19 and resistance is $2.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSDT stock will trade within this expected range on the day.